IBDEI04T ; ; 01-AUG-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,11646,2)
;;=^5007421
;;^UTILITY(U,$J,358.3,11647,0)
;;=I69.891^^50^538^21
;;^UTILITY(U,$J,358.3,11647,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11647,1,3,0)
;;=3^Dysphagia following other cerebrovascular disease
;;^UTILITY(U,$J,358.3,11647,1,4,0)
;;=4^I69.891
;;^UTILITY(U,$J,358.3,11647,2)
;;=^5007547
;;^UTILITY(U,$J,358.3,11648,0)
;;=I69.321^^50^538^22
;;^UTILITY(U,$J,358.3,11648,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11648,1,3,0)
;;=3^Dysphasia following cerebral infarction
;;^UTILITY(U,$J,358.3,11648,1,4,0)
;;=4^I69.321
;;^UTILITY(U,$J,358.3,11648,2)
;;=^5007492
;;^UTILITY(U,$J,358.3,11649,0)
;;=I69.121^^50^538^23
;;^UTILITY(U,$J,358.3,11649,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11649,1,3,0)
;;=3^Dysphasia following nontraumatic intracerebral hemorrhage
;;^UTILITY(U,$J,358.3,11649,1,4,0)
;;=4^I69.121
;;^UTILITY(U,$J,358.3,11649,2)
;;=^5007428
;;^UTILITY(U,$J,358.3,11650,0)
;;=I69.021^^50^538^24
;;^UTILITY(U,$J,358.3,11650,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11650,1,3,0)
;;=3^Dysphasia following nontraumatic subarachnoid hemorrhage
;;^UTILITY(U,$J,358.3,11650,1,4,0)
;;=4^I69.021
;;^UTILITY(U,$J,358.3,11650,2)
;;=^5007396
;;^UTILITY(U,$J,358.3,11651,0)
;;=I69.821^^50^538^26
;;^UTILITY(U,$J,358.3,11651,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11651,1,3,0)
;;=3^Dysphasia following other cerebrovascular disease
;;^UTILITY(U,$J,358.3,11651,1,4,0)
;;=4^I69.821
;;^UTILITY(U,$J,358.3,11651,2)
;;=^5007523
;;^UTILITY(U,$J,358.3,11652,0)
;;=I69.221^^50^538^25
;;^UTILITY(U,$J,358.3,11652,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11652,1,3,0)
;;=3^Dysphasia following oth nontraumatic intracranial hemorrhage
;;^UTILITY(U,$J,358.3,11652,1,4,0)
;;=4^I69.221
;;^UTILITY(U,$J,358.3,11652,2)
;;=^5007460
;;^UTILITY(U,$J,358.3,11653,0)
;;=I69.392^^50^538^29
;;^UTILITY(U,$J,358.3,11653,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11653,1,3,0)
;;=3^Facial weakness following cerebral infarction
;;^UTILITY(U,$J,358.3,11653,1,4,0)
;;=4^I69.392
;;^UTILITY(U,$J,358.3,11653,2)
;;=^5007517
;;^UTILITY(U,$J,358.3,11654,0)
;;=I69.192^^50^538^30
;;^UTILITY(U,$J,358.3,11654,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11654,1,3,0)
;;=3^Facial weakness following nontraumatic intcrbl hemorrhage
;;^UTILITY(U,$J,358.3,11654,1,4,0)
;;=4^I69.192
;;^UTILITY(U,$J,358.3,11654,2)
;;=^5007454
;;^UTILITY(U,$J,358.3,11655,0)
;;=I69.292^^50^538^32
;;^UTILITY(U,$J,358.3,11655,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11655,1,3,0)
;;=3^Facial weakness following oth nontraumatic intcrn hemorrhage
;;^UTILITY(U,$J,358.3,11655,1,4,0)
;;=4^I69.292
;;^UTILITY(U,$J,358.3,11655,2)
;;=^5007486
;;^UTILITY(U,$J,358.3,11656,0)
;;=I69.092^^50^538^31
;;^UTILITY(U,$J,358.3,11656,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11656,1,3,0)
;;=3^Facial weakness following ntrm subarachnoid hemorrhage
;;^UTILITY(U,$J,358.3,11656,1,4,0)
;;=4^I69.092
;;^UTILITY(U,$J,358.3,11656,2)
;;=^5007422
;;^UTILITY(U,$J,358.3,11657,0)
;;=I69.892^^50^538^33
;;^UTILITY(U,$J,358.3,11657,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11657,1,3,0)
;;=3^Facial weakness following other cerebrovascular disease
;;^UTILITY(U,$J,358.3,11657,1,4,0)
;;=4^I69.892
;;^UTILITY(U,$J,358.3,11657,2)
;;=^5007548
;;^UTILITY(U,$J,358.3,11658,0)
;;=I69.351^^50^538^36
;;^UTILITY(U,$J,358.3,11658,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11658,1,3,0)
;;=3^Hemiplga fol cerebral infrc aff right dominant side
;;^UTILITY(U,$J,358.3,11658,1,4,0)
;;=4^I69.351
;;^UTILITY(U,$J,358.3,11658,2)
;;=^5007504
;;^UTILITY(U,$J,358.3,11659,0)
;;=I69.352^^50^538^35
;;^UTILITY(U,$J,358.3,11659,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11659,1,3,0)
;;=3^Hemiplga fol cerebral infrc aff left dominant side
;;^UTILITY(U,$J,358.3,11659,1,4,0)
;;=4^I69.352
;;^UTILITY(U,$J,358.3,11659,2)
;;=^5007505
;;^UTILITY(U,$J,358.3,11660,0)
;;=I69.353^^50^538^37
;;^UTILITY(U,$J,358.3,11660,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11660,1,3,0)
;;=3^Hemiplga fol cerebral infrc aff right nondom side
;;^UTILITY(U,$J,358.3,11660,1,4,0)
;;=4^I69.353
;;^UTILITY(U,$J,358.3,11660,2)
;;=^5007506
;;^UTILITY(U,$J,358.3,11661,0)
;;=I69.354^^50^538^38
;;^UTILITY(U,$J,358.3,11661,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11661,1,3,0)
;;=3^Hemiplga fol cerebral infrc affecting left nondom side
;;^UTILITY(U,$J,358.3,11661,1,4,0)
;;=4^I69.354
;;^UTILITY(U,$J,358.3,11661,2)
;;=^5007507
;;^UTILITY(U,$J,358.3,11662,0)
;;=I69.151^^50^538^41
;;^UTILITY(U,$J,358.3,11662,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11662,1,3,0)
;;=3^Hemiplga fol ntrm intcrbl hemor aff right dominant side
;;^UTILITY(U,$J,358.3,11662,1,4,0)
;;=4^I69.151
;;^UTILITY(U,$J,358.3,11662,2)
;;=^5007441
;;^UTILITY(U,$J,358.3,11663,0)
;;=I69.152^^50^538^39
;;^UTILITY(U,$J,358.3,11663,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11663,1,3,0)
;;=3^Hemiplga fol ntrm intcrbl hemor aff left dominant side
;;^UTILITY(U,$J,358.3,11663,1,4,0)
;;=4^I69.152
;;^UTILITY(U,$J,358.3,11663,2)
;;=^5007442
;;^UTILITY(U,$J,358.3,11664,0)
;;=I69.153^^50^538^42
;;^UTILITY(U,$J,358.3,11664,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11664,1,3,0)
;;=3^Hemiplga fol ntrm intcrbl hemor aff right nondom side
;;^UTILITY(U,$J,358.3,11664,1,4,0)
;;=4^I69.153
;;^UTILITY(U,$J,358.3,11664,2)
;;=^5007443
;;^UTILITY(U,$J,358.3,11665,0)
;;=I69.154^^50^538^40
;;^UTILITY(U,$J,358.3,11665,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11665,1,3,0)
;;=3^Hemiplga fol ntrm intcrbl hemor aff left nondom side
;;^UTILITY(U,$J,358.3,11665,1,4,0)
;;=4^I69.154
;;^UTILITY(U,$J,358.3,11665,2)
;;=^5007444
;;^UTILITY(U,$J,358.3,11666,0)
;;=I69.851^^50^538^47
;;^UTILITY(U,$J,358.3,11666,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11666,1,3,0)
;;=3^Hemiplga fol oth cerebvasc disease aff right dominant side
;;^UTILITY(U,$J,358.3,11666,1,4,0)
;;=4^I69.851
;;^UTILITY(U,$J,358.3,11666,2)
;;=^5007535
;;^UTILITY(U,$J,358.3,11667,0)
;;=I69.852^^50^538^48
;;^UTILITY(U,$J,358.3,11667,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11667,1,3,0)
;;=3^Hemiplga fol oth cerebvasc disease aff left dominant side
;;^UTILITY(U,$J,358.3,11667,1,4,0)
;;=4^I69.852
;;^UTILITY(U,$J,358.3,11667,2)
;;=^5007536
;;^UTILITY(U,$J,358.3,11668,0)
;;=I69.853^^50^538^49
;;^UTILITY(U,$J,358.3,11668,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11668,1,3,0)
;;=3^Hemiplga fol oth cerebvasc disease aff right nondom side
;;^UTILITY(U,$J,358.3,11668,1,4,0)
;;=4^I69.853
;;^UTILITY(U,$J,358.3,11668,2)
;;=^5007537
;;^UTILITY(U,$J,358.3,11669,0)
;;=I69.854^^50^538^50
;;^UTILITY(U,$J,358.3,11669,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11669,1,3,0)
;;=3^Hemiplga fol oth cerebvasc disease aff left nondom side
;;^UTILITY(U,$J,358.3,11669,1,4,0)
;;=4^I69.854
;;^UTILITY(U,$J,358.3,11669,2)
;;=^5007538
;;^UTILITY(U,$J,358.3,11670,0)
;;=I69.251^^50^538^51
;;^UTILITY(U,$J,358.3,11670,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11670,1,3,0)
;;=3^Hemiplga fol oth ntrm intcrn hemor aff right dominant side
;;^UTILITY(U,$J,358.3,11670,1,4,0)
;;=4^I69.251
;;^UTILITY(U,$J,358.3,11670,2)
;;=^5007473
;;^UTILITY(U,$J,358.3,11671,0)
;;=I69.252^^50^538^52
;;^UTILITY(U,$J,358.3,11671,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11671,1,3,0)
;;=3^Hemiplga fol oth ntrm intcrn hemor aff left dominant side
;;^UTILITY(U,$J,358.3,11671,1,4,0)
;;=4^I69.252
;;^UTILITY(U,$J,358.3,11671,2)
;;=^5007474
;;^UTILITY(U,$J,358.3,11672,0)
;;=I69.253^^50^538^53
;;^UTILITY(U,$J,358.3,11672,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11672,1,3,0)
;;=3^Hemiplga fol oth ntrm intcrn hemor aff right nondom side
;;^UTILITY(U,$J,358.3,11672,1,4,0)
;;=4^I69.253
;;^UTILITY(U,$J,358.3,11672,2)
;;=^5007475
;;^UTILITY(U,$J,358.3,11673,0)
;;=I69.254^^50^538^54
;;^UTILITY(U,$J,358.3,11673,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11673,1,3,0)
;;=3^Hemiplga fol oth ntrm intcrn hemor aff left nondom side
;;^UTILITY(U,$J,358.3,11673,1,4,0)
;;=4^I69.254
;;^UTILITY(U,$J,358.3,11673,2)
;;=^5007476
;;^UTILITY(U,$J,358.3,11674,0)
;;=I69.341^^50^538^55
;;^UTILITY(U,$J,358.3,11674,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11674,1,3,0)
;;=3^Monoplg low lmb fol cerebral infrc aff right dominant side
;;^UTILITY(U,$J,358.3,11674,1,4,0)
;;=4^I69.341
;;^UTILITY(U,$J,358.3,11674,2)
;;=^5007501
;;^UTILITY(U,$J,358.3,11675,0)
;;=I69.342^^50^538^56
;;^UTILITY(U,$J,358.3,11675,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11675,1,3,0)
;;=3^Monoplg low lmb fol cerebral infrc aff left dominant side
;;^UTILITY(U,$J,358.3,11675,1,4,0)
;;=4^I69.342
;;^UTILITY(U,$J,358.3,11675,2)
;;=^5133575
;;^UTILITY(U,$J,358.3,11676,0)
;;=I69.343^^50^538^57
;;^UTILITY(U,$J,358.3,11676,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11676,1,3,0)
;;=3^Monoplg low lmb fol cerebral infrc aff right nondom side
;;^UTILITY(U,$J,358.3,11676,1,4,0)
;;=4^I69.343
;;^UTILITY(U,$J,358.3,11676,2)
;;=^5007502
;;^UTILITY(U,$J,358.3,11677,0)
;;=I69.344^^50^538^58
;;^UTILITY(U,$J,358.3,11677,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11677,1,3,0)
;;=3^Monoplg low lmb fol cerebral infrc aff left nondom side
;;^UTILITY(U,$J,358.3,11677,1,4,0)
;;=4^I69.344
;;^UTILITY(U,$J,358.3,11677,2)
;;=^5133576
;;^UTILITY(U,$J,358.3,11678,0)
;;=I69.141^^50^538^59
;;^UTILITY(U,$J,358.3,11678,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11678,1,3,0)
;;=3^Monoplg low lmb fol ntrm intcrbl hemor aff right dom side
;;^UTILITY(U,$J,358.3,11678,1,4,0)
;;=4^I69.141
;;^UTILITY(U,$J,358.3,11678,2)
;;=^5007437
;;^UTILITY(U,$J,358.3,11679,0)
;;=I69.142^^50^538^60
;;^UTILITY(U,$J,358.3,11679,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11679,1,3,0)
;;=3^Monoplg low lmb fol ntrm intcrbl hemor aff left dom side
;;^UTILITY(U,$J,358.3,11679,1,4,0)
;;=4^I69.142
;;^UTILITY(U,$J,358.3,11679,2)
;;=^5133573
;;^UTILITY(U,$J,358.3,11680,0)
;;=I69.143^^50^538^61
;;^UTILITY(U,$J,358.3,11680,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11680,1,3,0)
;;=3^Monoplg low lmb fol ntrm intcrbl hemor aff right nondom side
;;^UTILITY(U,$J,358.3,11680,1,4,0)
;;=4^I69.143
;;^UTILITY(U,$J,358.3,11680,2)
;;=^5007438
;;^UTILITY(U,$J,358.3,11681,0)
;;=I69.144^^50^538^62
;;^UTILITY(U,$J,358.3,11681,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11681,1,3,0)
;;=3^Monoplg low lmb fol ntrm intcrbl hemor aff left nondom side
;;^UTILITY(U,$J,358.3,11681,1,4,0)
;;=4^I69.144
;;^UTILITY(U,$J,358.3,11681,2)
;;=^5007439
;;^UTILITY(U,$J,358.3,11682,0)
;;=I69.041^^50^538^63
;;^UTILITY(U,$J,358.3,11682,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11682,1,3,0)
;;=3^Monoplg low lmb fol ntrm subarach hemor aff right dom side
;;^UTILITY(U,$J,358.3,11682,1,4,0)
;;=4^I69.041
;;^UTILITY(U,$J,358.3,11682,2)
;;=^5007405
;;^UTILITY(U,$J,358.3,11683,0)
;;=I69.042^^50^538^64
;;^UTILITY(U,$J,358.3,11683,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11683,1,3,0)
;;=3^Monoplg low lmb fol ntrm subarach hemor aff left dom side
;;^UTILITY(U,$J,358.3,11683,1,4,0)
;;=4^I69.042
;;^UTILITY(U,$J,358.3,11683,2)
;;=^5133572
;;^UTILITY(U,$J,358.3,11684,0)
;;=I69.043^^50^538^65
;;^UTILITY(U,$J,358.3,11684,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11684,1,3,0)
;;=3^Monoplg low lmb fol ntrm subarach hemor aff r nondom side
;;^UTILITY(U,$J,358.3,11684,1,4,0)
;;=4^I69.043
;;^UTILITY(U,$J,358.3,11684,2)
;;=^5007406
;;^UTILITY(U,$J,358.3,11685,0)
;;=I69.044^^50^538^66
;;^UTILITY(U,$J,358.3,11685,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11685,1,3,0)
;;=3^Monoplg low lmb fol ntrm subarach hemor aff left nondom side
;;^UTILITY(U,$J,358.3,11685,1,4,0)
;;=4^I69.044
;;^UTILITY(U,$J,358.3,11685,2)
;;=^5007407
;;^UTILITY(U,$J,358.3,11686,0)
;;=I69.841^^50^538^69
;;^UTILITY(U,$J,358.3,11686,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11686,1,3,0)
;;=3^Monoplg low lmb fol oth cerebvasc disease aff right dom side
;;^UTILITY(U,$J,358.3,11686,1,4,0)
;;=4^I69.841
;;^UTILITY(U,$J,358.3,11686,2)
;;=^5007532
;;^UTILITY(U,$J,358.3,11687,0)
;;=I69.842^^50^538^70
;;^UTILITY(U,$J,358.3,11687,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11687,1,3,0)
;;=3^Monoplg low lmb fol oth cerebvasc disease aff left dom side
;;^UTILITY(U,$J,358.3,11687,1,4,0)
;;=4^I69.842
;;^UTILITY(U,$J,358.3,11687,2)
;;=^5133577
;;^UTILITY(U,$J,358.3,11688,0)
;;=I69.843^^50^538^67
;;^UTILITY(U,$J,358.3,11688,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11688,1,3,0)
;;=3^Monoplg low lmb fol oth cerebvasc dis aff right nondom side
;;^UTILITY(U,$J,358.3,11688,1,4,0)
;;=4^I69.843
;;^UTILITY(U,$J,358.3,11688,2)
;;=^5007533
;;^UTILITY(U,$J,358.3,11689,0)
;;=I69.844^^50^538^68
;;^UTILITY(U,$J,358.3,11689,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11689,1,3,0)
;;=3^Monoplg low lmb fol oth cerebvasc dis aff left nondom side
;;^UTILITY(U,$J,358.3,11689,1,4,0)
;;=4^I69.844
;;^UTILITY(U,$J,358.3,11689,2)
;;=^5133578
;;^UTILITY(U,$J,358.3,11690,0)
;;=I69.241^^50^538^71
;;^UTILITY(U,$J,358.3,11690,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11690,1,3,0)
;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff right dom side
;;^UTILITY(U,$J,358.3,11690,1,4,0)
;;=4^I69.241
;;^UTILITY(U,$J,358.3,11690,2)
;;=^5007469
;;^UTILITY(U,$J,358.3,11691,0)
;;=I69.242^^50^538^72
;;^UTILITY(U,$J,358.3,11691,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11691,1,3,0)
;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff left dom side
;;^UTILITY(U,$J,358.3,11691,1,4,0)
;;=4^I69.242
;;^UTILITY(U,$J,358.3,11691,2)
;;=^5133574
;;^UTILITY(U,$J,358.3,11692,0)
;;=I69.243^^50^538^73
;;^UTILITY(U,$J,358.3,11692,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11692,1,3,0)
;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff r nondom side
;;^UTILITY(U,$J,358.3,11692,1,4,0)
;;=4^I69.243
;;^UTILITY(U,$J,358.3,11692,2)
;;=^5007470
;;^UTILITY(U,$J,358.3,11693,0)
;;=I69.244^^50^538^74
;;^UTILITY(U,$J,358.3,11693,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11693,1,3,0)
;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff l nondom side
;;^UTILITY(U,$J,358.3,11693,1,4,0)
;;=4^I69.244
;;^UTILITY(U,$J,358.3,11693,2)
;;=^5007471
;;^UTILITY(U,$J,358.3,11694,0)
;;=G35.^^50^538^75
;;^UTILITY(U,$J,358.3,11694,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11694,1,3,0)
;;=3^Multiple sclerosis
;;^UTILITY(U,$J,358.3,11694,1,4,0)
;;=4^G35.
;;^UTILITY(U,$J,358.3,11694,2)
;;=^79761
;;^UTILITY(U,$J,358.3,11695,0)
;;=G20.^^50^538^76
;;^UTILITY(U,$J,358.3,11695,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11695,1,3,0)
;;=3^Parkinson's disease
;;^UTILITY(U,$J,358.3,11695,1,4,0)
;;=4^G20.
;;^UTILITY(U,$J,358.3,11695,2)
;;=^5003770
;;^UTILITY(U,$J,358.3,11696,0)
;;=G21.4^^50^538^77
;;^UTILITY(U,$J,358.3,11696,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11696,1,3,0)
;;=3^Vascular parkinsonism
;;^UTILITY(U,$J,358.3,11696,1,4,0)
;;=4^G21.4
;;^UTILITY(U,$J,358.3,11696,2)
;;=^5003776
;;^UTILITY(U,$J,358.3,11697,0)
;;=I69.051^^50^538^45
;;^UTILITY(U,$J,358.3,11697,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11697,1,3,0)
;;=3^Hemiplga fol ntrm subarach hemor aff right dominant side
;;^UTILITY(U,$J,358.3,11697,1,4,0)
;;=4^I69.051
;;^UTILITY(U,$J,358.3,11697,2)
;;=^5007409
;;^UTILITY(U,$J,358.3,11698,0)
;;=I69.052^^50^538^43
;;^UTILITY(U,$J,358.3,11698,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11698,1,3,0)
;;=3^Hemiplga fol ntrm subarach hemor aff left dominant side
;;^UTILITY(U,$J,358.3,11698,1,4,0)
;;=4^I69.052
;;^UTILITY(U,$J,358.3,11698,2)
;;=^5007410
;;^UTILITY(U,$J,358.3,11699,0)
;;=I69.053^^50^538^46
;;^UTILITY(U,$J,358.3,11699,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11699,1,3,0)
;;=3^Hemiplga fol ntrm subarach hemor aff right nondom side
;;^UTILITY(U,$J,358.3,11699,1,4,0)
;;=4^I69.053
;;^UTILITY(U,$J,358.3,11699,2)
;;=^5007411
;;^UTILITY(U,$J,358.3,11700,0)
;;=I69.054^^50^538^44
;;^UTILITY(U,$J,358.3,11700,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11700,1,3,0)
;;=3^Hemiplga fol ntrm subarach hemor aff left nondom side
;;^UTILITY(U,$J,358.3,11700,1,4,0)
;;=4^I69.054
;;^UTILITY(U,$J,358.3,11700,2)
;;=^5007412
;;^UTILITY(U,$J,358.3,11701,0)
;;=G11.10^^50^538^28
;;^UTILITY(U,$J,358.3,11701,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11701,1,3,0)
;;=3^Early-Onset Cerebellar Ataxia,Unspec
;;^UTILITY(U,$J,358.3,11701,1,4,0)
;;=4^G11.10
;;^UTILITY(U,$J,358.3,11701,2)
;;=^5159151
;;^UTILITY(U,$J,358.3,11702,0)
;;=G11.11^^50^538^34
;;^UTILITY(U,$J,358.3,11702,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11702,1,3,0)
;;=3^Friedreich Ataxia
;;^UTILITY(U,$J,358.3,11702,1,4,0)
;;=4^G11.11
;;^UTILITY(U,$J,358.3,11702,2)
;;=^5159152
;;^UTILITY(U,$J,358.3,11703,0)
;;=G11.19^^50^538^27
;;^UTILITY(U,$J,358.3,11703,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11703,1,3,0)
;;=3^Early-Onset Cerebellar Ataxia,Oth
;;^UTILITY(U,$J,358.3,11703,1,4,0)
;;=4^G11.19
;;^UTILITY(U,$J,358.3,11703,2)
;;=^5159153
;;^UTILITY(U,$J,358.3,11704,0)
;;=I50.41^^50^539^1
;;^UTILITY(U,$J,358.3,11704,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11704,1,3,0)
;;=3^Acute combined systolic and diastolic (congestive) hrt fail
;;^UTILITY(U,$J,358.3,11704,1,4,0)
;;=4^I50.41
;;^UTILITY(U,$J,358.3,11704,2)
;;=^5007248
;;^UTILITY(U,$J,358.3,11705,0)
;;=I50.31^^50^539^2
;;^UTILITY(U,$J,358.3,11705,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11705,1,3,0)
;;=3^Acute diastolic (congestive) heart failure
;;^UTILITY(U,$J,358.3,11705,1,4,0)
;;=4^I50.31
;;^UTILITY(U,$J,358.3,11705,2)
;;=^5007244
;;^UTILITY(U,$J,358.3,11706,0)
;;=I50.43^^50^539^3
;;^UTILITY(U,$J,358.3,11706,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11706,1,3,0)
;;=3^Acute on chronic combined systolic and diastolic hrt fail
;;^UTILITY(U,$J,358.3,11706,1,4,0)
;;=4^I50.43
;;^UTILITY(U,$J,358.3,11706,2)
;;=^5007250
;;^UTILITY(U,$J,358.3,11707,0)
;;=I50.33^^50^539^4
;;^UTILITY(U,$J,358.3,11707,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11707,1,3,0)
;;=3^Acute on chronic diastolic (congestive) heart failure
;;^UTILITY(U,$J,358.3,11707,1,4,0)
;;=4^I50.33
;;^UTILITY(U,$J,358.3,11707,2)
;;=^5007246
;;^UTILITY(U,$J,358.3,11708,0)
;;=I50.23^^50^539^5
;;^UTILITY(U,$J,358.3,11708,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11708,1,3,0)
;;=3^Acute on chronic systolic (congestive) heart failure
;;^UTILITY(U,$J,358.3,11708,1,4,0)
;;=4^I50.23
;;^UTILITY(U,$J,358.3,11708,2)
;;=^5007242
;;^UTILITY(U,$J,358.3,11709,0)
;;=I50.21^^50^539^6
;;^UTILITY(U,$J,358.3,11709,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11709,1,3,0)
;;=3^Acute systolic (congestive) heart failure
;;^UTILITY(U,$J,358.3,11709,1,4,0)
;;=4^I50.21
;;^UTILITY(U,$J,358.3,11709,2)
;;=^5007240
;;^UTILITY(U,$J,358.3,11710,0)
;;=I25.111^^50^539^7
;;^UTILITY(U,$J,358.3,11710,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11710,1,3,0)
;;=3^Athscl hrt disease of native cor art w ang pctrs w spasm
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI04T 19817 printed Apr 09, 2024@21:49:05 Page 2
IBDEI04T ; ; 01-AUG-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,11646,2)
+2 ;;=^5007421
+3 ;;^UTILITY(U,$J,358.3,11647,0)
+4 ;;=I69.891^^50^538^21
+5 ;;^UTILITY(U,$J,358.3,11647,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,11647,1,3,0)
+8 ;;=3^Dysphagia following other cerebrovascular disease
+9 ;;^UTILITY(U,$J,358.3,11647,1,4,0)
+10 ;;=4^I69.891
+11 ;;^UTILITY(U,$J,358.3,11647,2)
+12 ;;=^5007547
+13 ;;^UTILITY(U,$J,358.3,11648,0)
+14 ;;=I69.321^^50^538^22
+15 ;;^UTILITY(U,$J,358.3,11648,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,11648,1,3,0)
+18 ;;=3^Dysphasia following cerebral infarction
+19 ;;^UTILITY(U,$J,358.3,11648,1,4,0)
+20 ;;=4^I69.321
+21 ;;^UTILITY(U,$J,358.3,11648,2)
+22 ;;=^5007492
+23 ;;^UTILITY(U,$J,358.3,11649,0)
+24 ;;=I69.121^^50^538^23
+25 ;;^UTILITY(U,$J,358.3,11649,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,11649,1,3,0)
+28 ;;=3^Dysphasia following nontraumatic intracerebral hemorrhage
+29 ;;^UTILITY(U,$J,358.3,11649,1,4,0)
+30 ;;=4^I69.121
+31 ;;^UTILITY(U,$J,358.3,11649,2)
+32 ;;=^5007428
+33 ;;^UTILITY(U,$J,358.3,11650,0)
+34 ;;=I69.021^^50^538^24
+35 ;;^UTILITY(U,$J,358.3,11650,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,11650,1,3,0)
+38 ;;=3^Dysphasia following nontraumatic subarachnoid hemorrhage
+39 ;;^UTILITY(U,$J,358.3,11650,1,4,0)
+40 ;;=4^I69.021
+41 ;;^UTILITY(U,$J,358.3,11650,2)
+42 ;;=^5007396
+43 ;;^UTILITY(U,$J,358.3,11651,0)
+44 ;;=I69.821^^50^538^26
+45 ;;^UTILITY(U,$J,358.3,11651,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,11651,1,3,0)
+48 ;;=3^Dysphasia following other cerebrovascular disease
+49 ;;^UTILITY(U,$J,358.3,11651,1,4,0)
+50 ;;=4^I69.821
+51 ;;^UTILITY(U,$J,358.3,11651,2)
+52 ;;=^5007523
+53 ;;^UTILITY(U,$J,358.3,11652,0)
+54 ;;=I69.221^^50^538^25
+55 ;;^UTILITY(U,$J,358.3,11652,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,11652,1,3,0)
+58 ;;=3^Dysphasia following oth nontraumatic intracranial hemorrhage
+59 ;;^UTILITY(U,$J,358.3,11652,1,4,0)
+60 ;;=4^I69.221
+61 ;;^UTILITY(U,$J,358.3,11652,2)
+62 ;;=^5007460
+63 ;;^UTILITY(U,$J,358.3,11653,0)
+64 ;;=I69.392^^50^538^29
+65 ;;^UTILITY(U,$J,358.3,11653,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,11653,1,3,0)
+68 ;;=3^Facial weakness following cerebral infarction
+69 ;;^UTILITY(U,$J,358.3,11653,1,4,0)
+70 ;;=4^I69.392
+71 ;;^UTILITY(U,$J,358.3,11653,2)
+72 ;;=^5007517
+73 ;;^UTILITY(U,$J,358.3,11654,0)
+74 ;;=I69.192^^50^538^30
+75 ;;^UTILITY(U,$J,358.3,11654,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,11654,1,3,0)
+78 ;;=3^Facial weakness following nontraumatic intcrbl hemorrhage
+79 ;;^UTILITY(U,$J,358.3,11654,1,4,0)
+80 ;;=4^I69.192
+81 ;;^UTILITY(U,$J,358.3,11654,2)
+82 ;;=^5007454
+83 ;;^UTILITY(U,$J,358.3,11655,0)
+84 ;;=I69.292^^50^538^32
+85 ;;^UTILITY(U,$J,358.3,11655,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,11655,1,3,0)
+88 ;;=3^Facial weakness following oth nontraumatic intcrn hemorrhage
+89 ;;^UTILITY(U,$J,358.3,11655,1,4,0)
+90 ;;=4^I69.292
+91 ;;^UTILITY(U,$J,358.3,11655,2)
+92 ;;=^5007486
+93 ;;^UTILITY(U,$J,358.3,11656,0)
+94 ;;=I69.092^^50^538^31
+95 ;;^UTILITY(U,$J,358.3,11656,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,11656,1,3,0)
+98 ;;=3^Facial weakness following ntrm subarachnoid hemorrhage
+99 ;;^UTILITY(U,$J,358.3,11656,1,4,0)
+100 ;;=4^I69.092
+101 ;;^UTILITY(U,$J,358.3,11656,2)
+102 ;;=^5007422
+103 ;;^UTILITY(U,$J,358.3,11657,0)
+104 ;;=I69.892^^50^538^33
+105 ;;^UTILITY(U,$J,358.3,11657,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,11657,1,3,0)
+108 ;;=3^Facial weakness following other cerebrovascular disease
+109 ;;^UTILITY(U,$J,358.3,11657,1,4,0)
+110 ;;=4^I69.892
+111 ;;^UTILITY(U,$J,358.3,11657,2)
+112 ;;=^5007548
+113 ;;^UTILITY(U,$J,358.3,11658,0)
+114 ;;=I69.351^^50^538^36
+115 ;;^UTILITY(U,$J,358.3,11658,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,11658,1,3,0)
+118 ;;=3^Hemiplga fol cerebral infrc aff right dominant side
+119 ;;^UTILITY(U,$J,358.3,11658,1,4,0)
+120 ;;=4^I69.351
+121 ;;^UTILITY(U,$J,358.3,11658,2)
+122 ;;=^5007504
+123 ;;^UTILITY(U,$J,358.3,11659,0)
+124 ;;=I69.352^^50^538^35
+125 ;;^UTILITY(U,$J,358.3,11659,1,0)
+126 ;;=^358.31IA^4^2
+127 ;;^UTILITY(U,$J,358.3,11659,1,3,0)
+128 ;;=3^Hemiplga fol cerebral infrc aff left dominant side
+129 ;;^UTILITY(U,$J,358.3,11659,1,4,0)
+130 ;;=4^I69.352
+131 ;;^UTILITY(U,$J,358.3,11659,2)
+132 ;;=^5007505
+133 ;;^UTILITY(U,$J,358.3,11660,0)
+134 ;;=I69.353^^50^538^37
+135 ;;^UTILITY(U,$J,358.3,11660,1,0)
+136 ;;=^358.31IA^4^2
+137 ;;^UTILITY(U,$J,358.3,11660,1,3,0)
+138 ;;=3^Hemiplga fol cerebral infrc aff right nondom side
+139 ;;^UTILITY(U,$J,358.3,11660,1,4,0)
+140 ;;=4^I69.353
+141 ;;^UTILITY(U,$J,358.3,11660,2)
+142 ;;=^5007506
+143 ;;^UTILITY(U,$J,358.3,11661,0)
+144 ;;=I69.354^^50^538^38
+145 ;;^UTILITY(U,$J,358.3,11661,1,0)
+146 ;;=^358.31IA^4^2
+147 ;;^UTILITY(U,$J,358.3,11661,1,3,0)
+148 ;;=3^Hemiplga fol cerebral infrc affecting left nondom side
+149 ;;^UTILITY(U,$J,358.3,11661,1,4,0)
+150 ;;=4^I69.354
+151 ;;^UTILITY(U,$J,358.3,11661,2)
+152 ;;=^5007507
+153 ;;^UTILITY(U,$J,358.3,11662,0)
+154 ;;=I69.151^^50^538^41
+155 ;;^UTILITY(U,$J,358.3,11662,1,0)
+156 ;;=^358.31IA^4^2
+157 ;;^UTILITY(U,$J,358.3,11662,1,3,0)
+158 ;;=3^Hemiplga fol ntrm intcrbl hemor aff right dominant side
+159 ;;^UTILITY(U,$J,358.3,11662,1,4,0)
+160 ;;=4^I69.151
+161 ;;^UTILITY(U,$J,358.3,11662,2)
+162 ;;=^5007441
+163 ;;^UTILITY(U,$J,358.3,11663,0)
+164 ;;=I69.152^^50^538^39
+165 ;;^UTILITY(U,$J,358.3,11663,1,0)
+166 ;;=^358.31IA^4^2
+167 ;;^UTILITY(U,$J,358.3,11663,1,3,0)
+168 ;;=3^Hemiplga fol ntrm intcrbl hemor aff left dominant side
+169 ;;^UTILITY(U,$J,358.3,11663,1,4,0)
+170 ;;=4^I69.152
+171 ;;^UTILITY(U,$J,358.3,11663,2)
+172 ;;=^5007442
+173 ;;^UTILITY(U,$J,358.3,11664,0)
+174 ;;=I69.153^^50^538^42
+175 ;;^UTILITY(U,$J,358.3,11664,1,0)
+176 ;;=^358.31IA^4^2
+177 ;;^UTILITY(U,$J,358.3,11664,1,3,0)
+178 ;;=3^Hemiplga fol ntrm intcrbl hemor aff right nondom side
+179 ;;^UTILITY(U,$J,358.3,11664,1,4,0)
+180 ;;=4^I69.153
+181 ;;^UTILITY(U,$J,358.3,11664,2)
+182 ;;=^5007443
+183 ;;^UTILITY(U,$J,358.3,11665,0)
+184 ;;=I69.154^^50^538^40
+185 ;;^UTILITY(U,$J,358.3,11665,1,0)
+186 ;;=^358.31IA^4^2
+187 ;;^UTILITY(U,$J,358.3,11665,1,3,0)
+188 ;;=3^Hemiplga fol ntrm intcrbl hemor aff left nondom side
+189 ;;^UTILITY(U,$J,358.3,11665,1,4,0)
+190 ;;=4^I69.154
+191 ;;^UTILITY(U,$J,358.3,11665,2)
+192 ;;=^5007444
+193 ;;^UTILITY(U,$J,358.3,11666,0)
+194 ;;=I69.851^^50^538^47
+195 ;;^UTILITY(U,$J,358.3,11666,1,0)
+196 ;;=^358.31IA^4^2
+197 ;;^UTILITY(U,$J,358.3,11666,1,3,0)
+198 ;;=3^Hemiplga fol oth cerebvasc disease aff right dominant side
+199 ;;^UTILITY(U,$J,358.3,11666,1,4,0)
+200 ;;=4^I69.851
+201 ;;^UTILITY(U,$J,358.3,11666,2)
+202 ;;=^5007535
+203 ;;^UTILITY(U,$J,358.3,11667,0)
+204 ;;=I69.852^^50^538^48
+205 ;;^UTILITY(U,$J,358.3,11667,1,0)
+206 ;;=^358.31IA^4^2
+207 ;;^UTILITY(U,$J,358.3,11667,1,3,0)
+208 ;;=3^Hemiplga fol oth cerebvasc disease aff left dominant side
+209 ;;^UTILITY(U,$J,358.3,11667,1,4,0)
+210 ;;=4^I69.852
+211 ;;^UTILITY(U,$J,358.3,11667,2)
+212 ;;=^5007536
+213 ;;^UTILITY(U,$J,358.3,11668,0)
+214 ;;=I69.853^^50^538^49
+215 ;;^UTILITY(U,$J,358.3,11668,1,0)
+216 ;;=^358.31IA^4^2
+217 ;;^UTILITY(U,$J,358.3,11668,1,3,0)
+218 ;;=3^Hemiplga fol oth cerebvasc disease aff right nondom side
+219 ;;^UTILITY(U,$J,358.3,11668,1,4,0)
+220 ;;=4^I69.853
+221 ;;^UTILITY(U,$J,358.3,11668,2)
+222 ;;=^5007537
+223 ;;^UTILITY(U,$J,358.3,11669,0)
+224 ;;=I69.854^^50^538^50
+225 ;;^UTILITY(U,$J,358.3,11669,1,0)
+226 ;;=^358.31IA^4^2
+227 ;;^UTILITY(U,$J,358.3,11669,1,3,0)
+228 ;;=3^Hemiplga fol oth cerebvasc disease aff left nondom side
+229 ;;^UTILITY(U,$J,358.3,11669,1,4,0)
+230 ;;=4^I69.854
+231 ;;^UTILITY(U,$J,358.3,11669,2)
+232 ;;=^5007538
+233 ;;^UTILITY(U,$J,358.3,11670,0)
+234 ;;=I69.251^^50^538^51
+235 ;;^UTILITY(U,$J,358.3,11670,1,0)
+236 ;;=^358.31IA^4^2
+237 ;;^UTILITY(U,$J,358.3,11670,1,3,0)
+238 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff right dominant side
+239 ;;^UTILITY(U,$J,358.3,11670,1,4,0)
+240 ;;=4^I69.251
+241 ;;^UTILITY(U,$J,358.3,11670,2)
+242 ;;=^5007473
+243 ;;^UTILITY(U,$J,358.3,11671,0)
+244 ;;=I69.252^^50^538^52
+245 ;;^UTILITY(U,$J,358.3,11671,1,0)
+246 ;;=^358.31IA^4^2
+247 ;;^UTILITY(U,$J,358.3,11671,1,3,0)
+248 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff left dominant side
+249 ;;^UTILITY(U,$J,358.3,11671,1,4,0)
+250 ;;=4^I69.252
+251 ;;^UTILITY(U,$J,358.3,11671,2)
+252 ;;=^5007474
+253 ;;^UTILITY(U,$J,358.3,11672,0)
+254 ;;=I69.253^^50^538^53
+255 ;;^UTILITY(U,$J,358.3,11672,1,0)
+256 ;;=^358.31IA^4^2
+257 ;;^UTILITY(U,$J,358.3,11672,1,3,0)
+258 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff right nondom side
+259 ;;^UTILITY(U,$J,358.3,11672,1,4,0)
+260 ;;=4^I69.253
+261 ;;^UTILITY(U,$J,358.3,11672,2)
+262 ;;=^5007475
+263 ;;^UTILITY(U,$J,358.3,11673,0)
+264 ;;=I69.254^^50^538^54
+265 ;;^UTILITY(U,$J,358.3,11673,1,0)
+266 ;;=^358.31IA^4^2
+267 ;;^UTILITY(U,$J,358.3,11673,1,3,0)
+268 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff left nondom side
+269 ;;^UTILITY(U,$J,358.3,11673,1,4,0)
+270 ;;=4^I69.254
+271 ;;^UTILITY(U,$J,358.3,11673,2)
+272 ;;=^5007476
+273 ;;^UTILITY(U,$J,358.3,11674,0)
+274 ;;=I69.341^^50^538^55
+275 ;;^UTILITY(U,$J,358.3,11674,1,0)
+276 ;;=^358.31IA^4^2
+277 ;;^UTILITY(U,$J,358.3,11674,1,3,0)
+278 ;;=3^Monoplg low lmb fol cerebral infrc aff right dominant side
+279 ;;^UTILITY(U,$J,358.3,11674,1,4,0)
+280 ;;=4^I69.341
+281 ;;^UTILITY(U,$J,358.3,11674,2)
+282 ;;=^5007501
+283 ;;^UTILITY(U,$J,358.3,11675,0)
+284 ;;=I69.342^^50^538^56
+285 ;;^UTILITY(U,$J,358.3,11675,1,0)
+286 ;;=^358.31IA^4^2
+287 ;;^UTILITY(U,$J,358.3,11675,1,3,0)
+288 ;;=3^Monoplg low lmb fol cerebral infrc aff left dominant side
+289 ;;^UTILITY(U,$J,358.3,11675,1,4,0)
+290 ;;=4^I69.342
+291 ;;^UTILITY(U,$J,358.3,11675,2)
+292 ;;=^5133575
+293 ;;^UTILITY(U,$J,358.3,11676,0)
+294 ;;=I69.343^^50^538^57
+295 ;;^UTILITY(U,$J,358.3,11676,1,0)
+296 ;;=^358.31IA^4^2
+297 ;;^UTILITY(U,$J,358.3,11676,1,3,0)
+298 ;;=3^Monoplg low lmb fol cerebral infrc aff right nondom side
+299 ;;^UTILITY(U,$J,358.3,11676,1,4,0)
+300 ;;=4^I69.343
+301 ;;^UTILITY(U,$J,358.3,11676,2)
+302 ;;=^5007502
+303 ;;^UTILITY(U,$J,358.3,11677,0)
+304 ;;=I69.344^^50^538^58
+305 ;;^UTILITY(U,$J,358.3,11677,1,0)
+306 ;;=^358.31IA^4^2
+307 ;;^UTILITY(U,$J,358.3,11677,1,3,0)
+308 ;;=3^Monoplg low lmb fol cerebral infrc aff left nondom side
+309 ;;^UTILITY(U,$J,358.3,11677,1,4,0)
+310 ;;=4^I69.344
+311 ;;^UTILITY(U,$J,358.3,11677,2)
+312 ;;=^5133576
+313 ;;^UTILITY(U,$J,358.3,11678,0)
+314 ;;=I69.141^^50^538^59
+315 ;;^UTILITY(U,$J,358.3,11678,1,0)
+316 ;;=^358.31IA^4^2
+317 ;;^UTILITY(U,$J,358.3,11678,1,3,0)
+318 ;;=3^Monoplg low lmb fol ntrm intcrbl hemor aff right dom side
+319 ;;^UTILITY(U,$J,358.3,11678,1,4,0)
+320 ;;=4^I69.141
+321 ;;^UTILITY(U,$J,358.3,11678,2)
+322 ;;=^5007437
+323 ;;^UTILITY(U,$J,358.3,11679,0)
+324 ;;=I69.142^^50^538^60
+325 ;;^UTILITY(U,$J,358.3,11679,1,0)
+326 ;;=^358.31IA^4^2
+327 ;;^UTILITY(U,$J,358.3,11679,1,3,0)
+328 ;;=3^Monoplg low lmb fol ntrm intcrbl hemor aff left dom side
+329 ;;^UTILITY(U,$J,358.3,11679,1,4,0)
+330 ;;=4^I69.142
+331 ;;^UTILITY(U,$J,358.3,11679,2)
+332 ;;=^5133573
+333 ;;^UTILITY(U,$J,358.3,11680,0)
+334 ;;=I69.143^^50^538^61
+335 ;;^UTILITY(U,$J,358.3,11680,1,0)
+336 ;;=^358.31IA^4^2
+337 ;;^UTILITY(U,$J,358.3,11680,1,3,0)
+338 ;;=3^Monoplg low lmb fol ntrm intcrbl hemor aff right nondom side
+339 ;;^UTILITY(U,$J,358.3,11680,1,4,0)
+340 ;;=4^I69.143
+341 ;;^UTILITY(U,$J,358.3,11680,2)
+342 ;;=^5007438
+343 ;;^UTILITY(U,$J,358.3,11681,0)
+344 ;;=I69.144^^50^538^62
+345 ;;^UTILITY(U,$J,358.3,11681,1,0)
+346 ;;=^358.31IA^4^2
+347 ;;^UTILITY(U,$J,358.3,11681,1,3,0)
+348 ;;=3^Monoplg low lmb fol ntrm intcrbl hemor aff left nondom side
+349 ;;^UTILITY(U,$J,358.3,11681,1,4,0)
+350 ;;=4^I69.144
+351 ;;^UTILITY(U,$J,358.3,11681,2)
+352 ;;=^5007439
+353 ;;^UTILITY(U,$J,358.3,11682,0)
+354 ;;=I69.041^^50^538^63
+355 ;;^UTILITY(U,$J,358.3,11682,1,0)
+356 ;;=^358.31IA^4^2
+357 ;;^UTILITY(U,$J,358.3,11682,1,3,0)
+358 ;;=3^Monoplg low lmb fol ntrm subarach hemor aff right dom side
+359 ;;^UTILITY(U,$J,358.3,11682,1,4,0)
+360 ;;=4^I69.041
+361 ;;^UTILITY(U,$J,358.3,11682,2)
+362 ;;=^5007405
+363 ;;^UTILITY(U,$J,358.3,11683,0)
+364 ;;=I69.042^^50^538^64
+365 ;;^UTILITY(U,$J,358.3,11683,1,0)
+366 ;;=^358.31IA^4^2
+367 ;;^UTILITY(U,$J,358.3,11683,1,3,0)
+368 ;;=3^Monoplg low lmb fol ntrm subarach hemor aff left dom side
+369 ;;^UTILITY(U,$J,358.3,11683,1,4,0)
+370 ;;=4^I69.042
+371 ;;^UTILITY(U,$J,358.3,11683,2)
+372 ;;=^5133572
+373 ;;^UTILITY(U,$J,358.3,11684,0)
+374 ;;=I69.043^^50^538^65
+375 ;;^UTILITY(U,$J,358.3,11684,1,0)
+376 ;;=^358.31IA^4^2
+377 ;;^UTILITY(U,$J,358.3,11684,1,3,0)
+378 ;;=3^Monoplg low lmb fol ntrm subarach hemor aff r nondom side
+379 ;;^UTILITY(U,$J,358.3,11684,1,4,0)
+380 ;;=4^I69.043
+381 ;;^UTILITY(U,$J,358.3,11684,2)
+382 ;;=^5007406
+383 ;;^UTILITY(U,$J,358.3,11685,0)
+384 ;;=I69.044^^50^538^66
+385 ;;^UTILITY(U,$J,358.3,11685,1,0)
+386 ;;=^358.31IA^4^2
+387 ;;^UTILITY(U,$J,358.3,11685,1,3,0)
+388 ;;=3^Monoplg low lmb fol ntrm subarach hemor aff left nondom side
+389 ;;^UTILITY(U,$J,358.3,11685,1,4,0)
+390 ;;=4^I69.044
+391 ;;^UTILITY(U,$J,358.3,11685,2)
+392 ;;=^5007407
+393 ;;^UTILITY(U,$J,358.3,11686,0)
+394 ;;=I69.841^^50^538^69
+395 ;;^UTILITY(U,$J,358.3,11686,1,0)
+396 ;;=^358.31IA^4^2
+397 ;;^UTILITY(U,$J,358.3,11686,1,3,0)
+398 ;;=3^Monoplg low lmb fol oth cerebvasc disease aff right dom side
+399 ;;^UTILITY(U,$J,358.3,11686,1,4,0)
+400 ;;=4^I69.841
+401 ;;^UTILITY(U,$J,358.3,11686,2)
+402 ;;=^5007532
+403 ;;^UTILITY(U,$J,358.3,11687,0)
+404 ;;=I69.842^^50^538^70
+405 ;;^UTILITY(U,$J,358.3,11687,1,0)
+406 ;;=^358.31IA^4^2
+407 ;;^UTILITY(U,$J,358.3,11687,1,3,0)
+408 ;;=3^Monoplg low lmb fol oth cerebvasc disease aff left dom side
+409 ;;^UTILITY(U,$J,358.3,11687,1,4,0)
+410 ;;=4^I69.842
+411 ;;^UTILITY(U,$J,358.3,11687,2)
+412 ;;=^5133577
+413 ;;^UTILITY(U,$J,358.3,11688,0)
+414 ;;=I69.843^^50^538^67
+415 ;;^UTILITY(U,$J,358.3,11688,1,0)
+416 ;;=^358.31IA^4^2
+417 ;;^UTILITY(U,$J,358.3,11688,1,3,0)
+418 ;;=3^Monoplg low lmb fol oth cerebvasc dis aff right nondom side
+419 ;;^UTILITY(U,$J,358.3,11688,1,4,0)
+420 ;;=4^I69.843
+421 ;;^UTILITY(U,$J,358.3,11688,2)
+422 ;;=^5007533
+423 ;;^UTILITY(U,$J,358.3,11689,0)
+424 ;;=I69.844^^50^538^68
+425 ;;^UTILITY(U,$J,358.3,11689,1,0)
+426 ;;=^358.31IA^4^2
+427 ;;^UTILITY(U,$J,358.3,11689,1,3,0)
+428 ;;=3^Monoplg low lmb fol oth cerebvasc dis aff left nondom side
+429 ;;^UTILITY(U,$J,358.3,11689,1,4,0)
+430 ;;=4^I69.844
+431 ;;^UTILITY(U,$J,358.3,11689,2)
+432 ;;=^5133578
+433 ;;^UTILITY(U,$J,358.3,11690,0)
+434 ;;=I69.241^^50^538^71
+435 ;;^UTILITY(U,$J,358.3,11690,1,0)
+436 ;;=^358.31IA^4^2
+437 ;;^UTILITY(U,$J,358.3,11690,1,3,0)
+438 ;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff right dom side
+439 ;;^UTILITY(U,$J,358.3,11690,1,4,0)
+440 ;;=4^I69.241
+441 ;;^UTILITY(U,$J,358.3,11690,2)
+442 ;;=^5007469
+443 ;;^UTILITY(U,$J,358.3,11691,0)
+444 ;;=I69.242^^50^538^72
+445 ;;^UTILITY(U,$J,358.3,11691,1,0)
+446 ;;=^358.31IA^4^2
+447 ;;^UTILITY(U,$J,358.3,11691,1,3,0)
+448 ;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff left dom side
+449 ;;^UTILITY(U,$J,358.3,11691,1,4,0)
+450 ;;=4^I69.242
+451 ;;^UTILITY(U,$J,358.3,11691,2)
+452 ;;=^5133574
+453 ;;^UTILITY(U,$J,358.3,11692,0)
+454 ;;=I69.243^^50^538^73
+455 ;;^UTILITY(U,$J,358.3,11692,1,0)
+456 ;;=^358.31IA^4^2
+457 ;;^UTILITY(U,$J,358.3,11692,1,3,0)
+458 ;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff r nondom side
+459 ;;^UTILITY(U,$J,358.3,11692,1,4,0)
+460 ;;=4^I69.243
+461 ;;^UTILITY(U,$J,358.3,11692,2)
+462 ;;=^5007470
+463 ;;^UTILITY(U,$J,358.3,11693,0)
+464 ;;=I69.244^^50^538^74
+465 ;;^UTILITY(U,$J,358.3,11693,1,0)
+466 ;;=^358.31IA^4^2
+467 ;;^UTILITY(U,$J,358.3,11693,1,3,0)
+468 ;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff l nondom side
+469 ;;^UTILITY(U,$J,358.3,11693,1,4,0)
+470 ;;=4^I69.244
+471 ;;^UTILITY(U,$J,358.3,11693,2)
+472 ;;=^5007471
+473 ;;^UTILITY(U,$J,358.3,11694,0)
+474 ;;=G35.^^50^538^75
+475 ;;^UTILITY(U,$J,358.3,11694,1,0)
+476 ;;=^358.31IA^4^2
+477 ;;^UTILITY(U,$J,358.3,11694,1,3,0)
+478 ;;=3^Multiple sclerosis
+479 ;;^UTILITY(U,$J,358.3,11694,1,4,0)
+480 ;;=4^G35.
+481 ;;^UTILITY(U,$J,358.3,11694,2)
+482 ;;=^79761
+483 ;;^UTILITY(U,$J,358.3,11695,0)
+484 ;;=G20.^^50^538^76
+485 ;;^UTILITY(U,$J,358.3,11695,1,0)
+486 ;;=^358.31IA^4^2
+487 ;;^UTILITY(U,$J,358.3,11695,1,3,0)
+488 ;;=3^Parkinson's disease
+489 ;;^UTILITY(U,$J,358.3,11695,1,4,0)
+490 ;;=4^G20.
+491 ;;^UTILITY(U,$J,358.3,11695,2)
+492 ;;=^5003770
+493 ;;^UTILITY(U,$J,358.3,11696,0)
+494 ;;=G21.4^^50^538^77
+495 ;;^UTILITY(U,$J,358.3,11696,1,0)
+496 ;;=^358.31IA^4^2
+497 ;;^UTILITY(U,$J,358.3,11696,1,3,0)
+498 ;;=3^Vascular parkinsonism
+499 ;;^UTILITY(U,$J,358.3,11696,1,4,0)
+500 ;;=4^G21.4
+501 ;;^UTILITY(U,$J,358.3,11696,2)
+502 ;;=^5003776
+503 ;;^UTILITY(U,$J,358.3,11697,0)
+504 ;;=I69.051^^50^538^45
+505 ;;^UTILITY(U,$J,358.3,11697,1,0)
+506 ;;=^358.31IA^4^2
+507 ;;^UTILITY(U,$J,358.3,11697,1,3,0)
+508 ;;=3^Hemiplga fol ntrm subarach hemor aff right dominant side
+509 ;;^UTILITY(U,$J,358.3,11697,1,4,0)
+510 ;;=4^I69.051
+511 ;;^UTILITY(U,$J,358.3,11697,2)
+512 ;;=^5007409
+513 ;;^UTILITY(U,$J,358.3,11698,0)
+514 ;;=I69.052^^50^538^43
+515 ;;^UTILITY(U,$J,358.3,11698,1,0)
+516 ;;=^358.31IA^4^2
+517 ;;^UTILITY(U,$J,358.3,11698,1,3,0)
+518 ;;=3^Hemiplga fol ntrm subarach hemor aff left dominant side
+519 ;;^UTILITY(U,$J,358.3,11698,1,4,0)
+520 ;;=4^I69.052
+521 ;;^UTILITY(U,$J,358.3,11698,2)
+522 ;;=^5007410
+523 ;;^UTILITY(U,$J,358.3,11699,0)
+524 ;;=I69.053^^50^538^46
+525 ;;^UTILITY(U,$J,358.3,11699,1,0)
+526 ;;=^358.31IA^4^2
+527 ;;^UTILITY(U,$J,358.3,11699,1,3,0)
+528 ;;=3^Hemiplga fol ntrm subarach hemor aff right nondom side
+529 ;;^UTILITY(U,$J,358.3,11699,1,4,0)
+530 ;;=4^I69.053
+531 ;;^UTILITY(U,$J,358.3,11699,2)
+532 ;;=^5007411
+533 ;;^UTILITY(U,$J,358.3,11700,0)
+534 ;;=I69.054^^50^538^44
+535 ;;^UTILITY(U,$J,358.3,11700,1,0)
+536 ;;=^358.31IA^4^2
+537 ;;^UTILITY(U,$J,358.3,11700,1,3,0)
+538 ;;=3^Hemiplga fol ntrm subarach hemor aff left nondom side
+539 ;;^UTILITY(U,$J,358.3,11700,1,4,0)
+540 ;;=4^I69.054
+541 ;;^UTILITY(U,$J,358.3,11700,2)
+542 ;;=^5007412
+543 ;;^UTILITY(U,$J,358.3,11701,0)
+544 ;;=G11.10^^50^538^28
+545 ;;^UTILITY(U,$J,358.3,11701,1,0)
+546 ;;=^358.31IA^4^2
+547 ;;^UTILITY(U,$J,358.3,11701,1,3,0)
+548 ;;=3^Early-Onset Cerebellar Ataxia,Unspec
+549 ;;^UTILITY(U,$J,358.3,11701,1,4,0)
+550 ;;=4^G11.10
+551 ;;^UTILITY(U,$J,358.3,11701,2)
+552 ;;=^5159151
+553 ;;^UTILITY(U,$J,358.3,11702,0)
+554 ;;=G11.11^^50^538^34
+555 ;;^UTILITY(U,$J,358.3,11702,1,0)
+556 ;;=^358.31IA^4^2
+557 ;;^UTILITY(U,$J,358.3,11702,1,3,0)
+558 ;;=3^Friedreich Ataxia
+559 ;;^UTILITY(U,$J,358.3,11702,1,4,0)
+560 ;;=4^G11.11
+561 ;;^UTILITY(U,$J,358.3,11702,2)
+562 ;;=^5159152
+563 ;;^UTILITY(U,$J,358.3,11703,0)
+564 ;;=G11.19^^50^538^27
+565 ;;^UTILITY(U,$J,358.3,11703,1,0)
+566 ;;=^358.31IA^4^2
+567 ;;^UTILITY(U,$J,358.3,11703,1,3,0)
+568 ;;=3^Early-Onset Cerebellar Ataxia,Oth
+569 ;;^UTILITY(U,$J,358.3,11703,1,4,0)
+570 ;;=4^G11.19
+571 ;;^UTILITY(U,$J,358.3,11703,2)
+572 ;;=^5159153
+573 ;;^UTILITY(U,$J,358.3,11704,0)
+574 ;;=I50.41^^50^539^1
+575 ;;^UTILITY(U,$J,358.3,11704,1,0)
+576 ;;=^358.31IA^4^2
+577 ;;^UTILITY(U,$J,358.3,11704,1,3,0)
+578 ;;=3^Acute combined systolic and diastolic (congestive) hrt fail
+579 ;;^UTILITY(U,$J,358.3,11704,1,4,0)
+580 ;;=4^I50.41
+581 ;;^UTILITY(U,$J,358.3,11704,2)
+582 ;;=^5007248
+583 ;;^UTILITY(U,$J,358.3,11705,0)
+584 ;;=I50.31^^50^539^2
+585 ;;^UTILITY(U,$J,358.3,11705,1,0)
+586 ;;=^358.31IA^4^2
+587 ;;^UTILITY(U,$J,358.3,11705,1,3,0)
+588 ;;=3^Acute diastolic (congestive) heart failure
+589 ;;^UTILITY(U,$J,358.3,11705,1,4,0)
+590 ;;=4^I50.31
+591 ;;^UTILITY(U,$J,358.3,11705,2)
+592 ;;=^5007244
+593 ;;^UTILITY(U,$J,358.3,11706,0)
+594 ;;=I50.43^^50^539^3
+595 ;;^UTILITY(U,$J,358.3,11706,1,0)
+596 ;;=^358.31IA^4^2
+597 ;;^UTILITY(U,$J,358.3,11706,1,3,0)
+598 ;;=3^Acute on chronic combined systolic and diastolic hrt fail
+599 ;;^UTILITY(U,$J,358.3,11706,1,4,0)
+600 ;;=4^I50.43
+601 ;;^UTILITY(U,$J,358.3,11706,2)
+602 ;;=^5007250
+603 ;;^UTILITY(U,$J,358.3,11707,0)
+604 ;;=I50.33^^50^539^4
+605 ;;^UTILITY(U,$J,358.3,11707,1,0)
+606 ;;=^358.31IA^4^2
+607 ;;^UTILITY(U,$J,358.3,11707,1,3,0)
+608 ;;=3^Acute on chronic diastolic (congestive) heart failure
+609 ;;^UTILITY(U,$J,358.3,11707,1,4,0)
+610 ;;=4^I50.33
+611 ;;^UTILITY(U,$J,358.3,11707,2)
+612 ;;=^5007246
+613 ;;^UTILITY(U,$J,358.3,11708,0)
+614 ;;=I50.23^^50^539^5
+615 ;;^UTILITY(U,$J,358.3,11708,1,0)
+616 ;;=^358.31IA^4^2
+617 ;;^UTILITY(U,$J,358.3,11708,1,3,0)
+618 ;;=3^Acute on chronic systolic (congestive) heart failure
+619 ;;^UTILITY(U,$J,358.3,11708,1,4,0)
+620 ;;=4^I50.23
+621 ;;^UTILITY(U,$J,358.3,11708,2)
+622 ;;=^5007242
+623 ;;^UTILITY(U,$J,358.3,11709,0)
+624 ;;=I50.21^^50^539^6
+625 ;;^UTILITY(U,$J,358.3,11709,1,0)
+626 ;;=^358.31IA^4^2
+627 ;;^UTILITY(U,$J,358.3,11709,1,3,0)
+628 ;;=3^Acute systolic (congestive) heart failure
+629 ;;^UTILITY(U,$J,358.3,11709,1,4,0)
+630 ;;=4^I50.21
+631 ;;^UTILITY(U,$J,358.3,11709,2)
+632 ;;=^5007240
+633 ;;^UTILITY(U,$J,358.3,11710,0)
+634 ;;=I25.111^^50^539^7
+635 ;;^UTILITY(U,$J,358.3,11710,1,0)
+636 ;;=^358.31IA^4^2
+637 ;;^UTILITY(U,$J,358.3,11710,1,3,0)
+638 ;;=3^Athscl hrt disease of native cor art w ang pctrs w spasm
